Scotiabank Maintains Sector Outperform on Pfizer, Raises Price Target to $35

Benzinga · 1d ago
Scotiabank analyst Louise Chen maintains Pfizer (NYSE:PFE) with a Sector Outperform and raises the price target from $33 to $35.